(Q53529113)

15 May 2018

title

Tumor suppressor miR-145 reverses drug resistance by directly targeting DNA damage-related gene RAD18 in colorectal cancer. (English)

1 reference

15 May 2018

Erratum to: Tumor suppressor miR-145 reverses drug resistance by directly targeting DNA damage-related gene RAD18 in colorectal cancer.

1 reference

corrigendum / erratum

0 references

author name string

Rui-Lei Liu

1

1 reference

15 May 2018

Ye Dong

2

1 reference

15 May 2018

Yan-Zhen Deng

3

1 reference

15 May 2018

Wen-Jun Wang

4

1 reference

15 May 2018

Wei-Dong Li

5

1 reference

15 May 2018

publication date

27 April 2015

1 reference

15 May 2018

published in

Tumor Biology

1 reference

15 May 2018

volume

36

1 reference

15 May 2018

issue

7

1 reference

15 May 2018

page(s)

5011-5019

1 reference

15 May 2018

https://scigraph.springernature.com/pub.10.1007/s13277-015-3152-5

exact match

0 references

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

Capecitabine: a novel agent for the treatment of solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

The DNA damage response and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

Specific complex formation between yeast RAD6 and RAD18 proteins: a potential mechanism for targeting RAD6 ubiquitin-conjugating activity to DNA damage sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

The human RAD18 gene product interacts with HHR6A and HHR6B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

Enhanced genomic instability and defective postreplication repair in RAD18 knockout mouse embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

Replication protein A: a heterotrimeric, single-stranded DNA-binding protein required for eukaryotic DNA metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

MicroRNA-145 targets YES and STAT1 in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

MicroRNA-143 is a critical regulator of cell cycle activity in stem cells with co-overexpression of Akt and angiopoietin-1 via transcriptional regulation of Erk5/cyclin D1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

Mir-33 regulates cell proliferation and cell cycle progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

MicroRNA targeting specificity in mammals: determinants beyond seed pairing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

MYC regulation of CHK1 and CHK2 promotes radioresistance in a stem cell-like population of nasopharyngeal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

p53 represses c-Myc through induction of the tumor suppressor miR-145

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

Ubiquitylation of the 9-1-1 checkpoint clamp is independent of rad6-rad18 and DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

Cell cycle stage-specific roles of Rad18 in tolerance and repair of oxidative DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

RAD18 transmits DNA damage signalling to elicit homologous recombination repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

Dynamic localization of human RAD18 during the cell cycle and a functional connection with DNA double-strand break repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

RAD18 promotes DNA double-strand break repair during G1 phase through chromatin retention of 53BP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

Rad18 E3 ubiquitin ligase activity mediates Fanconi anemia pathway activation and cell survival following DNA Topoisomerase 1 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3152-5

miR-145 inhibits breast cancer cell growth through RTKN.

21 January 2018

1 reference

12 December 2020

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer

1 reference

12 December 2020

UV mutagenesis in radiation-sensitive strains of yeast

1 reference

12 December 2020

The forkhead box M1 transcription factor as a candidate of target for anti-cancer immunotherapy

1 reference

12 December 2020

1 reference

12 December 2020

[Ki67 as histochemical marker of cellular proliferative activity in breast cancer]

1 reference

12 December 2020

10.1007/S13277-015-3152-5

Identifiers

DOI

1 reference

15 May 2018

PubMed ID

25913620

1 reference

15 May 2018